About PANTHERx Rare
PANTHERx Rare is a company based in Pittsburgh (United States) founded in 2011 was acquired by Vistria in May 2022. PANTHERx Rare has raised $200 thousand across 1 funding round from investors including Centene, General Atlantic and Nautic Partners. PANTHERx Rare offers products and services including RxARECARE, Medication Delivery, and Clinical Programs. PANTHERx Rare operates in a competitive market with competitors including Centivo, Access Healthcare, MultiPlan, Omega Healthcare and Light Wave Dental, among others.
- Headquarter Pittsburgh, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pantherx Specialty Llc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PANTHERx Rare
PANTHERx Rare offers a comprehensive portfolio of products and services, including RxARECARE, Medication Delivery, and Clinical Programs.
Offers compassionate care and access to rare medications for patients.
Streamlines access to rare disease treatments for various stakeholders.
Optimizes outcomes for rare conditions through expert support services.
People of PANTHERx Rare
Unlock access to complete
Unlock access to complete
Funding Insights of PANTHERx Rare
PANTHERx Rare has successfully raised a total of $200K through 1 strategic funding round. The most recent funding activity was a Seed round of $200 thousand completed in February 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PANTHERx Rare
PANTHERx Rare has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Centene, General Atlantic and Nautic Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Nautic Partners is engaged in middle market private equity investments.
|
Locked | Locked | Locked | |
|
Private equity fund focused on global markets
|
Locked | Locked | Locked | |
|
A private investment firm focused on essential industries is operated.
|
Locked | Locked | Locked |
Investor details for PANTHERx Rare
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PANTHERx Rare
Investment portfolio details for PANTHERx Rare
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PANTHERx Rare
Detailed financials for PANTHERx Rare
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pantherx Rare Comparisons
Peer comparison for PANTHERx Rare
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PANTHERx Rare
PANTHERx Rare operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Centivo, Access Healthcare, MultiPlan, Omega Healthcare and Light Wave Dental, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of self funded health plan
|
|
| Locked | Locked | Locked |
Provider of revenue cycle management, BPO, IT, and finance and accounting services
|
|
| Locked | Locked | Locked |
Medical payment integrity and analytics services are provided by MultiPlan.
|
|
| Locked | Locked | Locked |
Healthcare outsourcing services are provided to various sectors.
|
|
| Locked | Locked | Locked |
Dental practice brokerage services are provided to facilitate transactions.
|
|
| Locked | Locked | Locked |
Software solutions for laboratory diagnostics are provided to healthcare.
|
Detailed competitors of PANTHERx Rare
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pantherx Rare
Complete news archive for PANTHERx Rare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PANTHERx Rare
PANTHERx Rare was founded in 2011 and raised its 1st funding round 7 years after it was founded.
PANTHERx Rare is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
PANTHERx Rare is a funded company, having raised a total of $200K across 1 funding round to date.
PANTHERx Rare was founded in 2011 in Pittsburgh, United States, within the healthcare sector focused on rare diseases. Specialty pharmacy operations are conducted, including the development of medical treatment plans, data analytics for patient outcomes, and call center support for access and adherence. Additional services such as reimbursement assistance and patient navigation are handled across the United States to facilitate therapy management.
PANTHERx Rare's top competitors include Centivo, Access Healthcare and Rennova Health.
PANTHERx Rare offers RxARECARE, Medication Delivery, and Clinical Programs.
PANTHERx Rare has 4 investors. Key investors include Centene, General Atlantic, Nautic Partners, and The Vistria Group.